Roche to strengthen gene therapy portfolio with Spark Therapeutics acquisition

Swiss pharmaceutical giant Roche has reached a major agreement to acquire the U.S.-based gene therapy company Spark Therapeutics in an all-cash deal valued at $4.3 ... Read More